0001735936-23-000001.txt : 20230912 0001735936-23-000001.hdr.sgml : 20230912 20230912160113 ACCESSION NUMBER: 0001735936-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230912 DATE AS OF CHANGE: 20230912 EFFECTIVENESS DATE: 20230912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Osteal Therapeutics, Inc. CENTRAL INDEX KEY: 0001735936 IRS NUMBER: 900939060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-491921 FILM NUMBER: 231250059 BUSINESS ADDRESS: STREET 1: 105 AVENIDA DE LA ESTRELLA STREET 2: SUITE 3 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 650-691-5030 MAIL ADDRESS: STREET 1: 105 AVENIDA DE LA ESTRELLA STREET 2: SUITE 3 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 FORMER COMPANY: FORMER CONFORMED NAME: Joint Purification Systems, Inc. DATE OF NAME CHANGE: 20180328 D 1 primary_doc.xml X0708 D LIVE 0001735936 Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 650-691-5030 DELAWARE Joint Purification Systems LLC Joint Purification Systems, Inc. Corporation true David Thompson c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Executive Officer Director Rushu Luo c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Judson Cooper c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Biren Mehta c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director David Cash c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Brian de Beaubien c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Douglas Kohrs c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Martin Sands c/o Osteal Therapeutics, Inc. 4835 LBJ Fwy Ste 520 Dallas TX TEXAS 75244 Director Pharmaceuticals Decline to Disclose 06b false 2023-08-29 false true false 0 23000000 22285675 714325 false 19 0 0 0 false Osteal Therapeutics, Inc. /s/ David Thompson David Thompson CEO 2023-09-11